在使用基于人群的数据的牛皮患者中,心脑血管疾病和全身抗牛皮治疗之间的关联:一个嵌套病例对照研究
Bo Ri Kim1,2, Kun Hee Lee3, Jinseob Kim4
1Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
The Journal of dermatology
|July 31, 2023
概括
在牛皮患者中,全身抗牛皮疗法的使用与心脑血管疾病 (CCVD) 的风险降低有关. 治疗时间的延长显示出对CCVD发展的保护作用.
科学领域:
- 皮肤病学 皮肤病学
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 牛皮是一种慢性炎症性疾病,具有心血管和脑血管疾病 (CCVD) 的风险增加.
- 系统性抗牛皮治疗对牛皮患者中CCVD风险的影响尚不清楚.
研究的目的:
- 调查系统性抗牛皮疗法与牛皮患者中发展CCVD的风险之间的关联.
- 为了评估治疗时间对CCVD风险的影响.
主要方法:
- 一项基于人口的嵌套病例控制研究,使用全国范围的韩国国民健康保险索赔数据库.
- 确定新诊断的牛皮病患者和跟踪的CCVD事件 (缺血性心脏病,心肌梗塞,脑梗塞,脑出血).
- 使用全身抗治疗治疗期 (PTP) 的计算比例和使用后勤回归分析.
主要成果:
- 总共分析了251,813名参与者,其中6,262人发展了CCVD事件.
- 患有较高PTP的患者显示CCVD风险明显降低 (P < 0.001).
- 10%的PTP增加与CCVD风险降低4% (OR 0.96;95% CI 0.930.99),与传统和生物疗法一致.
结论:
- 系统性抗牛皮治疗与牛皮患者的CCVD风险相反相关.
- 增加全身抗 psoriatic 治疗的持续时间可能会减少CCVD的发展.
- 这些发现凸显了牛皮全身治疗对心血管的潜在益处.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
52
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
52
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease III: Medical Management
20
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20


